Annals of Hepatology

Article	Citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature	108
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity	82
STAT3: A key regulator in liver fibrosis	77
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease	72
The liver in times of COVID-19: What hepatologists should know	65
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis	64
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review	62
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article	51
The effect of liver test abnormalities on the prognosis of COVID-19	47
Chemotherapy-associated steatohepatitis	47
Clinical treatment of cholangiocarcinoma: an updated comprehensive review	46
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies	46
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)	44
A systematic review and meta-analysis of the COVID-19 associated liver injury	43
Osteopontin – A potential biomarker of advanced liver disease	42
Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis	40
Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis	35
Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes	34
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases	34
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C	33
Silymarin is an ally against insulin resistance: A review	32
COVID-19 and the liver: What do we know after six months of the pandemic?	29
Standardization of conventional chemoembolization for hepatocellular carcinoma	29
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III	29
SARS-CoV-2 another kind of liver aggressor, how does it do that?	27

From Child-Pugh to MELD score and beyond: Taking a walk down memory lane	27
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease	26
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission	25
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation	24
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis	23
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population	23
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study	23
An Integrated Review of the Hepatorenal Syndrome	21
Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population	21
Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease	20
LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway	20
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver	20
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis	20
Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing	19
NRF-2 and nonalcoholic fatty liver disease	19
Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up	18
Prognostic value of liver biochemical parameters for COVID-19 mortality	18
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?	18
Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy	18
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis	18
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases	18
Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease	17
NAFLD: Challenges and opportunities to address the public health problem in Latin America	17
Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling	16
Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis	16
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study	16
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis	16
Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)	16
MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3	16
Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosis	16
Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study	16
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study	15
Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease	15
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways	15
MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3	15
Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis	15
A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)	14
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy	14
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?	14
Acid-base abnormalities and liver dysfunction	14
Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis	13
Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit	13
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR	13
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection	13
Liquid biopsy in chronic liver disease	13
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway	13
Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience	13
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review	13
The histone variant H3.3 regulates the transcription of the hepatitis B virus	12
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis	12

Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway	12
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network	12
Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology	12
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p	12
Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis	12
Hepatitis B virus in Lao dentists: A cross-sectional serological study	11
Liver function as a predictor of mortality in COVID-19: A retrospective study	11
Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis	11
Management of hepatocellular carcinoma recurrence after liver transplantation	11
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico	11
FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases	11
Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study	11
LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2	11
Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis	11
Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line	11
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension	11
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study	11
miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo	11
Management of COVID-19 patients with chronic liver diseases and liver transplants	11
Ocular manifestations of liver disease in children: Clinical aspects and implications	11
LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis	11
Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis	11
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis	10
Bacterial infections in cirrhosis: Current treatment	10
Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil	10
Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection	10
Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis	10
Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis	10
Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort	10
Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway	10
Dysregulated N6-methyladenosine (m6A) processing in hepatocellular carcinoma	9
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study	9
The impact of electronic medical record system implementation on HCV screening and continuum of care: a systematic review	9
New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease	9
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence	9
Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma	9
The impact of COVID-19 on the cascade of care of HCV in the US and China	9
N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis	9
Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis	9
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?	9
Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study	9
Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database	9
Possible roles of Golgi protein-73 in liver diseases	8
Position statement on the use of albumin in liver cirrhosis	8
Radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis	8
Hepatic steatosis and respiratory diseases: a new panorama	8
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials	8
Progression of intraductal papillary neoplasm of the bile duct (IPNB): A proposed model through the observation of patients with non-resected tumors	8
Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p	8
Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic	8
Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma	8
IGF-1 contributes to liver cancer development in diabetes patients by promoting autophagy	8
HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation	8
Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice	8
Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p	8
Alternative splicing and liver disease	8
Characteristics and outcomes of hospitalized patients with Wilson’s disease in the United States: A national survey	8
Infected hepatic echinococcosis. Clinical, therapeutic, and prognostic aspects. A systematic review	8
Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit	8
Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy	7
Artificial liver support system in pediatric acute liver failure due to mushroom poisoning: Case series	7
Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus	7
Role of CD98 in liver disease	7
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease	7
Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice	7
A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report	7
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population	7
IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4/NF-κB signaling mediated by down-regulation HMGB1	7
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management	7
Viral eradication restores normal iron status in chronic hepatitis C patients with abnormal iron studies	7
Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease	7
Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma	7
Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression	7
Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America	6
Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico	6
PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population	6
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action	6
An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A	6
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients	6
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant – A retrospective cohort analysis	6

Comparing hepatic steatosis distribution patterns between non-alcoholic fatty liver disease and fatty liver disease with chronic hepatitis B by second-harmonic generation/two-photon excited fluorescen	6
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil	6
Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures	6
The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis	6
Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study	6
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B	6
Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitis	6
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany	6
A hospital-based study of the prevalence of HBV, HCV, HIV, and liver disease among a low-income population in West Mexico	6
Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests	6
Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database	6
African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population	6
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil	6
Metabolic dysfunction: The silenced connection with fatty liver disease	6
The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population	6
Current approaches to hepatic encephalopathy	6
MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A	6
Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B	6
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics	5
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?	5
Liver resection for single large hepatocellular carcinoma: a prognostic factors study	5
The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis	5
Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis	5
Hepatic immune-mediatedadverseeffects of immune checkpoint inhibitors: analysis of real-life experience	5
Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review	5
Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis	5
Simultaneous Metabolic and Alcohol-associated Fatty Liver Disease (SMAFLD) and Simultaneous Metabolic and Alcohol-associated Steatohepatitis (SMASH)	5
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy	5
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD	5
Weekend admissions with ascites are associated with delayed paracentesis: A nationwide analysis of the ‘weekend effect’	5
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2	5
Immunotolerance in liver transplantation: a primer for the clinician	5
Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016	5
Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing	5
Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report	4
Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH	4
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis	4
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations	4
Cerebral hemodynamics in the non-alcoholic fatty liver	4
Turnera diffusa extract attenuates profibrotic, extracellular matrix and mitochondrial markers in activated human hepatic stellate cells (HSC)	4
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids	4
Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases	4
The treatment of diabetes in advanced liver disease: change of a paradigm	4
LncRNA EPIC1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with LET	4
Waitlist mortality in patients with autoimmune liver diseases	4
Safety and efficacy of common endoscopic treatments in patients with decompensated liver cirrhosis	4
Calling a stage-based treatment model for chronic liver diseases in China mainland	4
Body mass index implications in intrahepatic cholestasis of pregnancy and placental histopathological alterations	4
Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017	4
Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients	4
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up	4
Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival	4
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases	4
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort	4
Early living donor liver transplantation for alcohol-associated hepatitis	4
Liver diseases: Perspective from the Philippines	4
Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease	4
Circ_0008285 knockdown represses tumor development by miR-384/RRM2 axis in hepatocellular carcinoma	4
A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis	4
Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease	4
A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis	4
Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis	4
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study	4
Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma	4
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts	4
Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016	4
Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors	3
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists	3
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia	3
Post-liver transplant outcomes in patients with major psychiatric diagnosis in the United States	3
Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective	3
Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study	3
Alcohol-associated liver disease: Epidemiology and management	3
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases	3
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay	3
The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center	3
Requirement of cyclin-dependent kinase function for hepatitis B virus cccDNA synthesis as measured by digital PCR	3
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity	3
Maternal smoking during pregnancy is risk factor for gallbladder disease in offspring during adulthood: a prospective study from UK Biobank	3
Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States	3
The imperative for an updated cirrhosis surgical risk score	3
Mediterranean diet or genome-based nutrition diets in Latin America's clinical practice guidelines for managing chronic liver diseases?	3
Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database	3
Patients with alcohol-related liver disease hospitalized during the COVID-19 pandemic experienced worse outcomes	3
Unexpected findings of hepatitis B and delta infection in northeastern Brazil: A public health alert	3
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC	3
A thorny matter: Spur cell anemia	3
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study	3
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites	3
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals	3
Cost of illness of liver diseases in Japan	3
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents	3
Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis	3
Pregnancy in Chronic Liver Disease: Before and After Transplantation	3
Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma	3